Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Tel Aviv - Delayed Quote ILA

NRGene Technologies Ltd (NRGN.TA)

264.50
+14.20
+(5.67%)
At close: April 29 at 4:32:48 PM GMT+3

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in ILA.
NameTitlePayExercisedYear Born
Dr. Gil Ronen Ph.D. Co-Founder, CEO & Director 361k -- 1968
Mr. Ron Avraham Finance Director -- -- 1983
Dr. Kobi Baruch Ph.D. Chief Technology Officer -- -- 1976

NRGene Technologies Ltd

Golda Meir Street
5th Floor
Ness Ziona, 7403649
Israel
972 7 222 03750 https://www.nrgene.com
Sector: 
Technology
Full Time Employees: 
29

Description

NRGene Technologies Ltd, an AI genomics company, provides computational tools and develops advanced algorithms in North America, Europe, Middle East, Africa, Asia Pacific, and internationally. It offers software tools; and turnkey solutions to breeding agricultural and food technology companies, academia, research institutes, and agribiotech companies. The company also develops custom panels for various plants including wheat, canola, corn, soybean, maize, etc., as well as cannabis. NRGene Technologies Ltd was incorporated in 2009 and is based in Ness Ziona, Israel.

Corporate Governance

NRGene Technologies Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers